Inhibition of Uncoupling Protein Expression during Lactation: Role of ...

1 downloads 0 Views 716KB Size Report
XIAO QIU XIAO, KEVIN L. GROVE, BERNADETTE E. GRAYSON, AND M. SUSAN SMITH. Division of Neuroscience, Oregon National Primate Research Center ...
0013-7227/04/$15.00/0 Printed in U.S.A.

Endocrinology 145(2):830 – 838 Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2003-0836

Inhibition of Uncoupling Protein Expression during Lactation: Role of Leptin XIAO QIU XIAO, KEVIN L. GROVE, BERNADETTE E. GRAYSON,

AND

M. SUSAN SMITH

Division of Neuroscience, Oregon National Primate Research Center (X.Q.X., K.L.G., B.E.G., M.S.S.), and Department of Physiology and Pharmacology (M.S.S.), Oregon Health and Science University, Beaverton, Oregon 97006 Uncoupling proteins (UCPs) are mitochondrial proteins that play a role in regulation of energy expenditure by uncoupling respiration from ATP synthesis. Lactation is a physiological condition characterized by negative energy balance due to the loss of energy sources to the production of milk. The objective of the current study was to investigate whether UCP mRNA and protein expressions were altered during lactation compared with those after 48 h of fasting. Lactation significantly reduced serum leptin levels, and removal of pups for 48 h increased serum leptin to higher levels than those observed in control rats. Compared with control rats, mRNA expression of UCP1 and UCP3 in brown adipose tissue (BAT) was dramatically reduced during lactation and fasting. The reduction in mRNAs was reflected by a lowered UCP1 protein level, and to some extent, UCP3 protein. Treatment of lactating rats with exogenous leptin (3 mg/kg) or removal of pups for 48 h com-

pletely reversed the down-regulation of UCP1 and UCP3 mRNA expression in BAT, and pup removal led to a recovery of protein expression. In contrast to BAT, UCP3 expression in skeletal muscle was increased in fasted rats and decreased during lactation. Similar changes were observed in serum free fatty acid levels. These changes are consistent with the idea that the utilization of free fatty acids as a fuel source is spared during lactation. As in BAT, leptin treatment and removal of pups were able to restore changes in mRNA expression of UCP3 in skeletal muscle during lactation. The present results suggest that the inhibition of leptin secretion during lactation is involved in the down-regulation of UCP expression in BAT and skeletal muscle, which, in turn, is responsible for the decrease in metabolic fuel oxidation and thermogenesis. (Endocrinology 145: 830 – 838, 2004)

U

NCOUPLING PROTEINS (UCPs) are members of the mitochondrial carrier protein superfamily that function to uncouple oxidative phosphorylation by dissipating the mitochondrial proton gradient (1–3). It has been widely accepted that high expression of UCP1 in brown adipose tissue (BAT) in rodents is closely related to the thermogenesis of BAT and, therefore, increased energy expenditure. However, the roles of its novel homologs, UCP2 and UCP3, still remain unclear and controversial, even though they probably also function to regulate thermogenesis, fatty acid metabolism, and mitochondrial production of free radicals. Most notably, metabolic effects of numerous factors, such as neuropeptide Y (4), leptin (5, 6), thyroid hormone (7), and PRL (8, 9) have been shown to be involved in the regulation of UCP expression. Lactation is a physiological state associated with dramatic metabolic adaptations and changes in energy balance. A major increase in energy demand along with a decrease in adaptive thermogenesis occur during lactation (10, 11). This adaptation has been considered an energy-sparing mechanism to facilitate the availability of energy for milk production. In rodents, the thermogenic function of BAT decreases during lactation, as shown by tissue hypotrophy, a decrease in mitochondrial biogenesis, and an impaired expression of genes encoding UCPs (12, 13). However, little is known about

whether the expression of UCPs is changed in other important metabolic tissues such as skeletal muscle or whether other possible factors may be involved in the regulation of UCP expression in these tissues. A growing body of evidence indicates that leptin, a 16-kDa adipose cell-specific secreted protein, acting through the hypothalamus, plays an important role in decreasing appetite and controlling food intake (14, 15). However, an important component of leptin’s effect is increased energy expenditure, because when differences in food intake are controlled, leptin-treated animals still lose more weight (16). Most notably, leptin has been demonstrated to increase core body temperature (17), stimulate sympathetic nerve activity (18), and increase norepinephrine turnover in BAT (19). It has also been shown that decreased UCP1 expression in BAT of ob/ob mice, a model lacking leptin expression, is at least partially responsible for their increased metabolic efficiency and propensity to become obese. Furthermore, leptin stimulates energy utilization in ob/ob mice by inducing UCP1 activity (20). As UCPs are the main mediators of thermogenesis that play an important role in the modulation of energy balance, we hypothesize that alterations in the expression and function of UCPs might be involved in the major metabolic adaptations occurring during lactation. The present study is designed to examine the changes in expression of UCPs during lactation and compare them with those after 48-h fasting. We chose fasting as a positive control because it is another condition of negative energy balance with decreased thermogenesis, and the regulation of UCPs in this model has been well characterized (5). In addition, the effects of leptin treatment on UCP expression during lactation were examined.

Abbreviations: BAT, Brown adipose tissue; Fam, 6-carboxyfluorescein; FFA, free fatty acid; P0, d 0 postpartum; Tamra, 6-carboxytetramethylrhodamine; UCP, uncoupling protein. Endocrinology is published monthly by The Endocrine Society (http:// www.endo-society.org), the foremost professional society serving the endocrine community.

830

Xiao et al. • Leptin and UCP Expression during Lactation

Endocrinology, February 2004, 145(2):830 – 838 831

Materials and Methods Animals and tissues Pregnant and virgin cycling female Sprague Dawley rats (Simonsen, Gilroy, CA) were housed with a 12-h light, 12-h dark photoperiod (lights on at 0700 h) in a temperature-controlled room (21–22 C). The day of delivery was considered d 0 postpartum (P0), and litters were adjusted to eight pups on P2. Lactating rats were allowed free access to rat chow and water and were allowed to suckle their eight pups undisturbed until P9, at which time they were divided into three groups: lactation, suckled eight pups until P11; lactation plus leptin, suckled eight pups and received recombinant mouse leptin (3 mg/kg, ip; Amgen, Inc., Thousand Oaks, CA) at 1600 h on P9 and P10; and pup removal, pups permanently removed at 1500 h on P9. All groups were killed by decapitation after 1500 h on P11. Cycling female rats were similarly killed after 48 h of fasting or without any previous food deprivation on diestrus, as examined by daily vaginal smears. Food and water intake for the 24-h period before rats were killed are reported in Table 1. Trunk blood was collected at the time of decapitation. Interscapular brown adipose tissue (BAT) and hindlimb gastrocnemius skeletal muscle were quickly removed and dissected free of connective tissues. The tissues were stored at ⫺80 C. All animal procedures were approved by the Oregon National Primate Research Center institutional animal care and use committee.

Serum leptin and free fatty acid (FFA) assays Trunk blood samples were allowed to clot on ice and were centrifuged for 20 min at 2000 ⫻ g, and serum was stored at ⫺20 C until use. Leptin was assayed by using a rat leptin RIA kit (Linco Research, Inc., St. Charles, MO). On the day of RIA, samples were slowly thawed, and 100 ␮l serum were taken and added to the RIA tubes. Standard concentrations ranged between 0.5–50 ng/ml, which is within the limit of linearity. All samples were examined in the same assay, with an intraassay coefficient of variance of 7%. The colorimetric FFA assay was used to quantify the total nonesterified FFAs according to the manufacturer’s instructions (Wako Chemicals, Richmond, VA). Briefly, 25 ␮l serum were added to a 500-␮l mixture containing 0.3 U/ml acyl-coenzyme A synthetase, 3 mg/ml ATP, 3 mmol/liter magnesium chloride, 0.7 mg/ml coenzyme A, 3 U/ml ascorbate oxidase, and 0.3 mg/ml 4-aminoantipyrine, and incubated at 37 C for 10 min, followed by a reaction with 66 U/ml acyl-coenzyme A oxidase, 75 U/ml peroxidase, and 1.2 mmol/liter 3-methyl-N-ethyl-N-(␣-hydroxy-ethyl)-aniline to form a purple color that is read colorimetrically at 550 nm. The intraassay coefficient of variance of this assay was 5.5%. The amount of FFA in the sample is directly proportional to the intensity of the color produced and is expressed as milliequivalents per liter of standard oleic acid (ranging from 0 –2 mEq/liter).

RNA isolation and real-time RT-PCR BAT and skeletal muscle were homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA), and total cellular RNA was isolated according to the manufacturer’s specifications. The quality and concentration of the RNA were determined by measuring the absorbance at 260 and 280 nm, and RNA completeness was confirmed by RNA gel. Real-time PCR

was used to quantify UCP mRNA levels (21). The principle of TaqMan real-time PCR is based on DNA amplification and cleavage of an internal probe that is hybridized to the amplified DNA by the 5⬘-3⬘ exonuclease activity of the Taq DNA polymerase during PCR cycles. RNA samples were prepared for real-time PCR by random primed RT reaction using random hexamer primers (Promega Corp., Madison, WI) and 1 ␮g RNA. The RT reaction was then diluted 1:50 for PCR analysis. Reactions were conducted in triplicate for increased accuracy. Ten microliters of reaction mixture contained 5 ␮l TaqMan Universal PCR Master Mix, 300 nm specific target gene primers, 80 nm 18S RNA gene primers, 250 nm specific probes, and 2 ␮l cDNA. The amplification was performed as follows: 2 min at 50 C, 10 min at 95 C, then 40 cycles each at 95 C for 15 sec and 60 C for 60 sec in the ABI PRISM 7700 Sequences Detector System (PE Applied Biosystems, Foster City, CA). After PCR was completed, baseline and threshold values were set to optimize the amplification plot, and the data were exported to an Excel spreadsheet. Standard curves were drawn on the basis of the log of the input RNA vs. the critical threshold cycle, which is the cycle in which the fluorescence of the sample was greater than the threshold of baseline fluorescence. These standard curves allowed for the critical threshold values to be converted to relative RNA concentrations for each sample. 18S RNA amplifications were conducted with the Pre-Developed TaqMan Assay Reagent (PE Applied Biosystems), and other primers and probes were designed using Primer Express software from PE Applied Biosystems. The sequences of primers and probes used were as follows: UCP1 forward, TCC CTC AGG ATT GGC CTC TAC; UCP1 reverse, GTC ATC AAG CCA GCC GAG AT; UCP1 probe, 6-carboxyfluorescein (Fam)AACGCCTGCCTCTTTGGGAAGCAA-6-carboxytetramethylrhodamine (Tamra); UCP2 forward, GTT TCA AGG CCA CCG ATG TG; UCP2 reverse, GGG AAA GTG ATG AGA TCT GCA AT; UCP2 probe, Fam-CCCCACAGCCACCGTGAAGTCCCT-Tamra; UCP3 forward, ACT GGA GGC GAG AGG AAA TAC A; UCP3 reverse, ATG TTG GGC CAA GTC CCT TT; and UCP3 probe, Fam-CCCTGACTCCTTCCTCCCTGGCGA-Tamra.

Mitochondrial protein preparation and Western blot Procedures for mitochondrial protein preparation were described previously (22). BAT and skeletal muscle were weighed and placed in isolation medium (100 mm KCl, 50 mm Tris-HCl, and 2 mm EDTA, pH 7.4) on ice. All of the following steps were performed at 4 C. Tissues were shredded with a sharp blade, minced with sharp scissors, rinsed with isolation medium four or five times, stirred for 2 min in the homogenizing medium [100 mm KCl, 50 mm Tris-HCl, 2 mm EDTA, 1 mm ATP, 5 mm MgCl2, 0.2% BSA, and 18.7 U protease (protease type VIII, SigmaAldrich Corp., St. Louis, MO)/g tissues, pH 7.4], and gently homogenized using a Polytron tissue homogenizer (Brinkmann Instruments, Westbury, NY). The homogenate was stirred for 3 min, then centrifuged at 490 ⫻ g for 10 min. The supernatant was filtered through muslin and centrifuged at 10,368 ⫻ g for 10 min. Mitochondrial-enriched pellets were resuspended in isolation medium, combined, and centrifuged at 10,368 ⫻ g for 10 min and then at 3,841 ⫻ g for 10 min, and resuspended in isolation medium. The protein concentration was determined using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). Samples containing mitochondrial protein from BAT (20 ␮g) or skeletal muscle (60 ␮g) were mixed with 2⫻ sodium dodecyl sulfate loading

TABLE 1. Food and water intake and serum leptin and free fatty acid (FFA) levels during fasting and lactation

Food intake (g/100 g BW) Water intake (g/100 g BW) BW (g) Serum leptin (ng/ml) Serum FFA (mEq/liter)

Diestrus (n ⫽ 6 – 8)

Fasted (n ⫽ 7– 8)

5.66 ⫾ 0.57 11.57 ⫾ 1.27 244.3 ⫾ 20.3 1.34 ⫾ 0.15 0.41 ⫾ 0.15

N/A 4.36 ⫾ 0.59a 219.4 ⫾ 16.8a 0.27 ⫾ 0.02a 1.17 ⫾ 0.22a

Lactation 8 pups (n ⫽ 6 –7)

8 pups ⫹ leptin (n ⫽ 6)

0 pups (n ⫽ 6 –7)

17.85 ⫾ 1.71a 29.31 ⫾ 2.87a 315.1 ⫾ 15.5a 0.37 ⫾ 0.03a 0.20 ⫾ 0.06a

16.1 ⫾ 3.47a 23.9 ⫾ 5.2a,b 290.9 ⫾ 14.4a 0.66 ⫾ 0.24a 0.19 ⫾ 0.05a

6.63 ⫾ 0.75b 15.97 ⫾ 2.02a,b 325.5 ⫾ 27.3a 4.76 ⫾ 1.85a,b 0.34 ⫾ 0.03b

Cycling SD rats were either ad libitum fed (diestrus) or fasted for 48 h (fasted). Day 11 lactating rats received no treatment (8 pups) or were pretreated with leptin (8 pups ⫹ leptin) or removal of pups for 48 h (0 pups). Daily food and water intakes were measured for 24 h before the day rats were killed, and the amount was normalized to 100 g body weight (BW). All data were presented as the mean ⫾ SEM. a Significantly different from diestrus. b Significantly different from 8 pups (P ⬍ 0.05, by t test).

832

Endocrinology, February 2004, 145(2):830 – 838

buffer, incubated at 90 C for 5 min, electrophoresed on 12% PAGE Gold Precast Gels (Cambrex Bio Science, Rockland, ME), and then transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories). After transfer, membranes were blocked with blocking buffer (Pierce Chemical Co., Rockford, IL) for 1 h at room temperature and incubated with polyclonal anti-UCP1 (1:10,000), anti-UCP2 (1:1,000), and anti-UCP3 (1:5,000); all antibodies were made in goats (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). After washing, the membranes were further incubated with donkey antigoat horseradish peroxidase-conjugated secondary antibody (1:10,000; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Immunoreactive products were detected using enhanced chemiluminescence (Pierce Chemical Co.) and exposed to XOMAT sheet film (Eastman Kodak Co., Rochester, NY). Protein levels were quantified using the video-based image analysis system (Scion Image, Scion Corp., Frederick, MD). The protein levels were determined by multiplying the area of the band by the average OD of the band.

Statistical analysis Data are expressed as the mean ⫾ sem. One-way ANOVA, followed by the Newman-Keuls multiple range test or t test, was used to determine significant differences among groups.

Results Food and water intake, body weight, and serum leptin and FFA levels

Table 1 reports 24-h food and water intake, body weight (measured on the day rats were killed) and serum leptin and FFA levels in the various groups in this study. Food and water consumption during the 24 h before rats were killed were normalized and expressed as grams per 100 g body weight. Food and water intakes in lactating animals were 3to 4-fold higher than those in normal cycling rats. Leptin treatment did not significantly change food intake, but decreased water intake by 20%, whereas removal of the pups for 48 h (0 pups) reduced food and water intakes to levels similar to those in diestrous controls. All lactating rats were significantly heavier than diestrous rats. Compared with cycling diestrous rats, both fasted and lactating animals had a significant decrease in serum leptin levels. The decrease induced by lactation was not fully restored by exogenous leptin. However, it should be noted that these animals were killed 24 h after the last leptin injection; thus, most of the exogenous leptin would be cleared by that time. Removal of pups for 48 h resulted in serum leptin levels significantly higher than those observed in diestrous animals, as previously reported (23). Compared with control, diestrous rats, fasting increased serum FFA levels by 1.9-fold. In contrast, lactation significantly reduced FFA levels by 50%, and leptin treatment had no effect to restore FFAs to controls. However, removal of pups did restore FFA levels to control values. Changes in mRNA levels of UCPs in BAT

Figure 1, A–D, demonstrates the amplification plots of UCP1, UCP2, UCP3, and 18 S RNA, which was selected as a reference standard to normalize the DNA quality and quantity among different samples. At a 10-fold serial dilution, all of the tested genes showed good amplification plots starting from 20 pg and yielded standard curves with correlation coefficients higher than 0.99 (Fig. 1, E–H). Three types of UCPs are expressed in BAT, with UCP1 being the most abundant, followed by UCP2 and UCP3 (24). Figure 2 shows the changes in expression of UCP1 (A), UCP2

Xiao et al. • Leptin and UCP Expression during Lactation

(B), and UCP3 (C) mRNAs in the study. As expected, fasting almost fully abolished UCP1 mRNA expression in BAT. Similarly, UCP1 mRNA expression was reduced 70% during lactation. To determine whether leptin is associated with lactation-induced down-regulation of UCP1, the effects of injection of leptin or removal of pups for 2 d were examined. The reduction in UCP1 mRNA during lactation was reversed by either exogenous leptin replacement or removal of the pups. Furthermore, administration of leptin increased UCP1 mRNA expression to a value significantly higher than that observed in control diestrous rats. In contrast to UCP1, UCP2 mRNA levels did not differ among the various groups. Changes in UCP3 mRNA expression in BAT were similar to those in UCP1. Both fasting and lactation significantly diminished the expression of UCP3 mRNA, and the effect of lactation was reversed by leptin administration or removal of the pups. Changes in mRNA levels of UCPs in skeletal muscle

Figure 3 shows UCP2 (A) and UCP3 (B) mRNA levels in the gastrocnemius muscle in the various groups. UCP2 mRNA was not changed under any of the tested experimental conditions. UCP3 mRNA expression was increased 3-fold in response to fasting. In contrast, lactating rats demonstrated a dramatically lowered expression of UCP3 mRNA. Again, treatment with leptin or removal of the pups reversed the effect of lactation on UCP3 mRNA expression in skeletal muscle. Changes in the mitochondrial UCP protein content in BAT

To assess whether protein levels of UCPs in the mitochondria paralleled changes in UCP mRNA expression, immunoblot assays were performed using specific antibodies to the different subtypes of UCPs. Analysis of mitochondrial proteins from interscapular BAT resulted in the detection of a band corresponding to 32 kDa (Fig. 4A). Densitometric analysis demonstrated about a 50% decrease in UCP1 protein in response to fasting. Similarly, UCP1 protein was decreased 70% during lactation. Interestingly, leptin treatment did not result in a recovery of UCP1 protein, as it did in mRNA levels (Fig. 2). However, removal of pups for 48 h did restore UCP1 protein levels (Fig. 4A, upper row, and Fig. 4B). In agreement with mRNA levels of UCP2 in BAT, mitochondrial UCP2 proteins remained unaltered during fasting or lactation (Fig. 4A, middle row, and Fig. 4C). Similar to changes in UCP1 protein, densitometric analysis showed that fasting and lactation decreased UCP3 protein by 20% and 50%, respectively, compared with that in diestrous rats. Leptin administration did not significantly alter the lactation-induced downregulation of UCP3 protein, but removal of pups for 48 h completely restored UCP3 protein levels (Fig. 4A, lower row, and Fig. 4D). Changes in the mitochondrial UCP contents of in skeletal muscle

We then examined UCP2 and UCP3 mitochondrial proteins in skeletal muscle. Similar to the results in BAT, the UCP2 band was weak, and no noticeable change was ob-

Xiao et al. • Leptin and UCP Expression during Lactation

Endocrinology, February 2004, 145(2):830 – 838 833

FIG. 1. Representative amplification plots and standard curves for real-time PCR. A–D, Amplification plots of UCP1, UCP2, UCP3, and 18 S RNA, which was selected as a reference standard to normalize the DNA quality and quantity from different samples in BAT; E–H, corresponding standard curves.

served under current treatments in skeletal muscle (Fig. 5A, upper row, and Fig. 5B). In agreement with a previous report (25), fasting induced a significant increase in UCP3 protein level, which correlates with its large increase in mRNA expression. A 50% decrease by densitometric analysis in UCP3 protein level was observed during lactation compared with diestrous controls. However, unlike the observation of UCP3 mRNA expression in the same tissues, leptin administration did not fully reverse the lactation-induced down-regulation

of UCP3 protein, whereas removal of pups was fully effective (Fig. 5A, lower row, and Fig. 5C). Discussion

In the present study we have used models of fasting (48 h) and lactation to examine changes in mRNA and protein of UCP homologs in BAT and skeletal muscle. We also examined key factors associated with lactation, such as the low

834

Endocrinology, February 2004, 145(2):830 – 838

Xiao et al. • Leptin and UCP Expression during Lactation

FIG. 3. Changes in UCP2 (A) and UCP3 (B) mRNAs in skeletal muscle. Total RNA was extracted with TRIzol reagent from hindlimb skeletal muscle, and mRNA expression was assessed by real-time RT-PCR. Columns with differing superscripts (a, b, or c) indicate values that are significantly different from each other. For UCP2: F ⫽ 2.359; df ⫽ 4; P ⫽ 0.0882; for UCP3: F ⫽ 42.73; df ⫽ 4; P ⬍ 0.0001 (by one-way ANOVA, followed by Newman-Keuls multiple range test). See Fig. 2 for additional details.

FIG. 2. Changes in UCP1 (A), UCP2 (B), and UCP3 (C) mRNAs in BAT. Cycling rats were either ad libitum fed (Diestrus) or fasted for 48 h (Fasted). Day 11 lactating rats received no treatment (8 Pups) or were pretreated with leptin (8 Pups⫹Leptin) or removal of pups for 48 h (0 Pups). Total RNA was extracted with TRIzol reagent from interscapular BAT, and mRNA expression was assessed by real-time RT-PCR. Columns with differing superscripts (a, b, or c) indicate values that are significantly different from each other. For UCP1: F ⫽ 78.19; df ⫽ 4; P ⬍ 0.0001; for UCP2: F ⫽ 2.171; df ⫽ 4; P ⫽ 0.1094; for UCP3: F ⫽ 16.08; df ⫽ 4; P ⬍ 0.0001 (by one-way ANOVA, followed by Newman-Keuls multiple range test).

levels of leptin and the metabolic drain of milk production, to determine their roles in driving the energy-sparing adaptation that occurs during lactation. In agreement with previous studies (5, 25–27), we demonstrate here that in response to fasting, UCP1 and UCP3 mRNA expression, but not UCP2 expression, in BAT was dramatically reduced, whereas UCP1 protein was only moderately decreased, and UCP3 protein was not significantly changed. These results suggest that in BAT, decreased UCP levels, mainly UCP1, are the major factors responsible for energy conservation during fasting. Lactation is a natural model of chronic negative energy balance and is characterized by the suppression of pulsatile LH secretion, increases in serum oxytocin and PRL levels, and a large increase in food intake, with relatively normal serum insulin and glucose levels and slightly elevated basal corticosterone levels (10, 11, 23, 28). There are several over-

Xiao et al. • Leptin and UCP Expression during Lactation

Endocrinology, February 2004, 145(2):830 – 838 835

FIG. 4. Changes in UCP1, UCP2, and UCP3 protein expression in BAT. A, Representative Western bands of UCP1, UCP2, and UCP3 in BAT. B, C, and D, Densitometric analysis for UCP1, UCP2, and UCP3, respectively. Mitochondrial proteins were extracted as described in Materials and Methods from interscapular BAT, and protein expression was assessed by Western blot. Columns with differing superscripts (a or b) indicate values that are significantly different from each other. For UCP1: F ⫽ 8.305; df ⫽ 4; P ⫽ 0.001; for UCP2: F ⫽ 2.208; df ⫽ 4; P ⫽ 0.1173; for UCP3: F ⫽ 9.877; df ⫽ 4; P ⫽ 0.0004 (by one-way ANOVA, followed by Newman-Keuls multiple range test). See Fig. 2 for additional details.

lapping physiological adaptations between fasting and lactation despite the food deprivation in the former and the hyperphagia in the latter. For instance, fasted and lactating rats have decreased adaptive thermogenesis and low circulating leptin levels (10, 11, 23, 29), as confirmed in the present studies. Due to these similarities, it was expected that UCP expression in BAT would be similarly regulated in these models. Indeed, both BAT UCP1 and UCP3 expression were similarly decreased during fasting and lactation, and lactating animals also had a significant reduction in UCP1 and UCP3 protein levels. Therefore, the reduction in BAT UCP1 and UCP3 expression may be part of the metabolic adaptations and energy sparing that occur during lactation. The mechanism behind the changes in UCP1 and UCP3 could be due to many factors, including the decrease in sympathetic nervous system activity or hormonal changes associated with lactation, i.e. leptin, PRL, and oxytocin (8, 9, 30). One likely factor is leptin, which has been shown to be an important regulator of UCP expression (20). However, the mechanisms responsible for the remarkable reduction in serum leptin observed during lactation are unclear. After removal of the pups, leptin and insulin reach higher than normal levels, most likely reflecting the high level of adi-

posity present during lactation (23). These results also suggest that leptin secretion is actively suppressed during lactation. The suckling stimulus alone, in the absence of the metabolic drain associated with milk production, does not result in a suppression of leptin secretion, indicating the importance of the metabolic drain. However, it is unknown what factors may be acting on adipose tissue to suppress leptin production during lactation, but it is unlikely to be oxytocin or PRL, because these hormones are increased by the suckling stimulus in the absence or presence of a metabolic drain (11, 23). There are several reports about the effect of PRL on leptin production. PRL suppressed insulininduced leptin secretion in cultured adipocytes (31), but stimulated it in vivo in transgenic female mice that either overexpressed PRL (31) or were PRL receptor deficient (32) as well as in rats treated with exogenous PRL (33). The significance of these effects of PRL on leptin secretion remains to be elucidated, but it is clear from our previous results that during lactation, leptin and PRL are modulated independently. Leptin treatment prevents the decrease in UCP1 and UCP3 expression caused by fasting (5, 25, 26). Consistent with the situation during fasting, low circulating leptin levels during

836

Endocrinology, February 2004, 145(2):830 – 838

FIG. 5. Changes in UCP2 and UCP3 protein expression in skeletal muscle. A, Representative Western bands of UCP2 and UCP3 in skeletal muscle. B and C, Densitometric analysis for UCP2 and UCP3. Columns with differing superscripts (a, b, or c) indicate values that are significantly different from each other. For UCP2: F ⫽ 2.845; df ⫽ 4; P ⫽ 0.0614; for UCP3: F ⫽ 28.78; df ⫽ 4; P ⬍ 0.0001 (by one-way ANOVA, followed by Newman-Keuls multiple range test). See Fig. 2 for additional details.

lactation could be the cause of the decrease in UCP1 and UCP3 expression. Indeed, leptin replacement during midlactation significantly increased UCP1 and UCP3 mRNA expression; however, neither UCP1 nor UCP3 protein levels were altered by this treatment, suggesting that leptin may be able to directly stimulate BAT UCP1 and UCP3 mRNA expression, but does not directly alter protein expression. In contrast, removal of the nursing pups for 48 h, a model of natural hyperleptinemia, resulted in a full recovery of UCP1 and UCP3 mRNA and protein levels. It should be noted that in this model, there is also a removal of the energy drain due to milk production, reduced PRL levels (23), and normal FFA levels, all of which may be necessary for the full recovery of

Xiao et al. • Leptin and UCP Expression during Lactation

UCP protein levels. PRL has also been shown to inhibit UCP1 content in BAT (8, 9). Therefore, it is possible that sucklinginduced hyperprolactinemia may play a role in the regulation of UCP1 expression in BAT. Its effect on UCP3 expression has not been reported. In conclusion, low circulating leptin levels during fasting and, at least in part during lactation, may be responsible for the fall in BAT UCP1 and UCP3 expression, allowing for energy conservation. One major difference between fasted and lactating rats is that circulating FFA levels are elevated during fasting but reduced during lactation due to the increased FFA uptake by mammary tissue (34). This difference may be a reason for the divergent effects of fasting and lactation on UCP3 expression in skeletal muscle despite the low serum leptin levels in these conditions. The remarkable increase in UCP3 expression during fasting agrees with previous reports (25, 35, 36). Skeletal muscle is the primary tissue responsible for the clearance of dietary glucose and lipids from circulation. During fasting, when the overall strategy is to conserve energy and to spare glucose for use by the brain, the fuel requirement of skeletal muscle is diminished, and its predominant fuel is shifted toward lipids. UCP3 is likely to be specifically involved in regulating the use of lipids as fuel substrates in skeletal muscle (37–39). This hypothesis is supported by our present study and evidence showing an up-regulation of UCP3 in skeletal muscle under conditions where the preference for fuel substrate is shifted toward lipids, such as in fasting and high fat feeding (25, 39). Furthermore, mice lacking UCP3 showed a tendency toward impairment in the starvationinduced shift in fatty acid metabolism (40). It has also been demonstrated that the increased UCP3 expression in skeletal muscle in response to fasting is due to high circulating FFAs, because infusion of FFAs into ad libitum-fed animals caused similar increases in UCP3 expression (41). Leptin has also shown to increase UCP3 expression in ad libitum-fed animals, an effect that is thought to be indirect through modulation of changes in FFAs. Therefore, it is not surprising that in fasted rats, treatment with leptin does not further increase UCP3 expression (25, 41). In contrast to the fasted rat, UCP3 is significantly decreased in skeletal muscle during lactation. This decrease is compatible with two physiological events: a reduction in nonshivering thermogenesis (42) and a decrease in the utilization of fatty acids by muscle, which favors the delivery of these substrates to the mammary gland for milk production (34, 43). Lactating animals that have had the nursing pups removed for 48 h are hyperleptinemic, have normal FFA levels, and show a full recovery of UCP3 mRNA and protein expression. In contrast, lactating rats treated with leptin have low FFA levels and increased UCP3 mRNA expression, but only partial recovery of UCP3 protein levels. Therefore, the levels of FFAs do not appear to be a critical factor for leptin to stimulate UCP3 mRNA expression, although they may be a key determinant for regulating UCP3 protein levels. The stimulatory effect of leptin on UCP3 mRNA expression in skeletal muscle during lactation is similar to that reported for ad libitum-fed animals (25). Overall, these data point toward a stimulatory action of leptin on UCP1 and UCP3 expression in BAT and skeletal muscle. However, we do not know from these studies

Xiao et al. • Leptin and UCP Expression during Lactation

whether these effects are mediated solely via direct actions on BAT and skeletal muscle or through indirect methods, such as modulation of sympathetic tone through actions in the central nervous system (44). The importance of the removal of the central actions of leptin during lactation is supported by evidence from our laboratory that neuropeptide Y and proopiomelanocortin expressions within the hypothalamus are significantly increased and suppressed, respectively, in this model (11). The changes in these hypothalamic neuropeptides would not only support the orexigenic drive necessary to meet the energy demands of milk production, but would also decrease energy expenditure through suppression of sympathetic tone. The changes in UCP expression that we observed here are consistent with the decrease in sympathetic tone that has been reported during lactation (30). In summary, we observed both similarities and differences between fasting and lactation in the regulation of UCP expression in BAT and skeletal muscle. Both fasting and lactation caused a similar down-regulation of UCP1 and UCP3 in BAT, which would be consistent with energy conservation through a decrease in nonshivering thermogenesis. The differences observed in the regulation of UCP3 in skeletal muscle (increase in fasting, decrease in lactation) may represent different energy-sparing adaptations. Further investigation is needed to elucidate which neurotransmitters and signaling pathways are involved in the regulation of UCP expression during lactation. Acknowledgments Received July 7, 2003. Accepted October 28, 2003. Address all correspondence and requests for reprints to: Dr. M. Susan Smith, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006. E-mail: [email protected]. This work was supported by NIH Grants HD-14643, HD-18185, and RR-00163.

References 1. Argiles JM, Busquets S, Lopez-Soriano FJ 2002 The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293:1145– 1152 2. Argyropoulos G, Harper ME 2002 Uncoupling proteins and thermoregulation. J Appl Physiol 92:2187–2198 3. Pecqueur C, Couplan E, Bouillaud F, Ricquier D 2001 Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J Mol Med 79:48 –56 4. Kotz CM, Wang CF, Briggs JE, Levine AS, Billington CJ 2000 Effect of NPY in the hypothalamic paraventricular nucleus on uncoupling proteins 1, 2, and 3 in the rat. Am J Physiol 278:R494 –R498 5. Sivitz WI, Fink BD, Morgan DA, Fox JM, Donohoue PA, Haynes WG 1999 Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats. Am J Physiol 277:E668 –E677 6. Commins SP, Watson PM, Frampton IC, Gettys TW 2001 Leptin selectively reduces white adipose tissue in mice via a UCP1-dependent mechanism in brown adipose tissue. Am J Physiol Endocrinol Metab 280:E372–E377 7. Jekabsons MB, Gregoire FM, Schonfeld-Warden NA, Warden CH, Horwitz BA 1999 T(3) stimulates resting metabolism and UCP-2 and UCP-3 mRNA but not nonphosphorylating mitochondrial respiration in mice. Am J Physiol 277: E380 –E389 8. Pearce S, Dieguez C, Gualillo O, Symonds ME, Stephenson T 2003 Differential effects of age and sex on the postnatal responsiveness of brown adipose tissue to prolactin administration in rats. Exp Physiol 88:527–531 9. Chan E, Swaminathan R 1990 Role of prolactin in lactation-induced changes in brown adipose tissue. Am J Physiol 258:R51–R56 10. Dewey KG 1997 Energy and protein requirements during lactation. Annu Rev Nutr 17:19 –36

Endocrinology, February 2004, 145(2):830 – 838 837

11. Smith MS, Grove KL 2002 Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 23:225– 256 12. Trayhurn P, Gouglas JB, McGuckin MM 1982 Brown adipose tissue thermogenesis is suppressed during lactation in mice. Nature 298:59 – 69 13. Pedraza N, Solanes G, Iglesias R, Vazquez M, Giralt M, Villarroya F 2001 Differential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in mice. Biochem J 355:105–111 14. Campfield LA, Smith FJ, Burn P 1996 The OB protein (leptin) pathway: a link between adipose tissue mass and central neural networks. Horm Metab Res 28:619 – 632 15. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878 – 8883 16. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546 17. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540 –543 18. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI 1997 Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270 –278 19. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS 1996 Role of leptin in fat regulation. Nature 380:677 20. Commins SP, Watson PM, Padgett MA, Dudley A, Argyropoulos G, Gettys TW 1999 Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology 140:292–300 21. Sekhon HS, Keller JA, Proskocil BJ, Martin EL, and Spindel ER 2002 Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung: association with 7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 26:31– 41 22. Cadenas S, Echtay KS, Harper JA, Jekabsons MB, Buckingham JA, Grau E, Abuin A, Chapman H, Clapham JC, Brand MD 2002 The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J Biol Chem 277:2773–2778 23. Brogan RS, Mitchell SE, Trayhurn P, Smith MS 1999 Suppression of leptin during lactation: contribution of the suckling stimulus versus milk production. Endocrinology 140:2621–2627 24. Ricquier D, Bouillaud F 2000 The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 345:161–179 25. Sivitz WI, Fink BD, Donohoue PA 1999 Fasting and leptin modulate adipose and muscle uncoupling protein: divergent effects between messenger ribonucleic acid and protein expression. Endocrinology 140:1511–1519 26. Scarpace PJ, Nicolson M, Matheny M 1998 UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin. J Endocrinol 159:349 – 357 27. Champigny O, Ricquier D 1990 Effects of fasting and refeeding on the level of uncoupling protein mRNA in rat brown adipose tissue: evidence for dietinduced and cold-induced responses. J Nutr 120:1730 –1736 28. Walker CD, Lightman SL, Steele MK, Dallman MF 1992 Suckling is a persistent stimulus to the adrenocortical system of the rat. Endocrinology 130: 115–125 29. Patel BK, Koenig JI, Kaplan LM, Hooi SC 1998 Increase in plasma leptin and Lep mRNA concentrations by food intake is dependent on insulin. Metabolism 47:603– 607 30. McNamara JP, Murray CE 2001 Sympathetic nervous system activity in adipose tissues during pregnancy and lactation of the rat. J Dairy Sci 84:1382–1389 31. Ling C, Billig H 2001 PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. Endocrinology 142:4880 – 4890 32. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P 2001 Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142:532–537 33. Gualillo O, Lago F, Garcia M, Menendez C, Senaris R, Casanueva FF, Dieguez C 1999 Prolactin stimulates leptin secretion by rat white adipose tissue. Endocrinology 140:5149 –5153 34. Del Prado M, Villalpando S, Gordillo J, Hernandez-Montes H 1999 A high dietary lipid intake during pregnancy and lactation enhances mammary gland lipid uptake and lipoprotein lipase activity in rats. J Nutr 129:1574 –1578 35. Pedersen SB, Borglum JD, Kristensen K, Norrelund H, Otto J, Jorgensen L, Richelsen B 2000 Regulation of uncoupling protein (UCP) 2 and 3 in adipose and muscle tissue by fasting and growth hormone treatment in obese humans. Int J Obes Relat Metab Disord 24:968 –975 36. Zhou M, Lin BZ, Coughlin S, Vallega G, Pilch PF 2000 UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol 279:E622–E629 37. Schrauwen P, Hesselink M 2002 UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol 205:2275–2285

838

Endocrinology, February 2004, 145(2):830 – 838

38. Schrauwen P, Saris WH, Hesselink MK 2001 An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 15:2497– 2502 39. Chou CJ, Cha MC, Jung DW, Boozer CN, Hashim SA, Pi-Sunyer FX 2001 High-fat diet feeding elevates skeletal muscle uncoupling protein 3 levels but not its activity in rats. Obes Res 9:313–319 40. Bezaire V, Hofmann W, Kramer JK, Kozak LP, Harper ME 2001 Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3⫺/⫺ and wild-type mice. Am J Physiol 281:E975–E982

Xiao et al. • Leptin and UCP Expression during Lactation

41. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H 1998 Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47:298 –302 42. Trayhurn P 1983 Decreased capacity for non-shivering thermogenesis during lactation in mice. Pflugers Arch 398:264 –265 43. Williamson DH 1989 Regulation of metabolism during lactation in the rats. Reprod Nutr Dev 26:597– 603 44. Elmquist JK 2001 Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav 74:703–708

Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost professional society serving the endocrine community.